Literature DB >> 16007212

Human diploid fibroblasts are resistant to MEK/ERK-mediated disruption of the actin cytoskeleton and invasiveness stimulated by Ras.

Taiko Sukezane1, Chitose Oneyama, Kyoko Kakumoto, Kana Shibutani, Hidesaburo Hanafusa, Tsuyoshi Akagi.   

Abstract

Ras-induced transformation is characterized not only by uncontrolled proliferation but also by drastic morphological changes accompanied by the disruption of the actin cytoskeleton. Previously, we reported that human fibroblasts are more resistant than rodent fibroblasts to Ras-induced transformation. To explore the molecular basis for the difference in susceptibility to Ras-induced transformation, we investigated the effect of activated H-Ras on the actin cytoskeleton in human diploid fibroblasts and in rat embryo fibroblasts, both of which are immortalized by SV40 early region. We demonstrate here that Ras-induced morphological changes, decreased expression of tropomyosin isoforms, and suppression of the ROCK/LIMK/Cofilin pathway observed in the rat fibroblasts were not detected in the human fibroblasts even with high expression levels of Ras. We also show that activation of the MEK/ERK pathway sufficed to induce all of these alterations in the rat fibroblasts, whereas the human fibroblasts were refractory to these MEK/ERK-mediated changes. In addition to morphological changes, we demonstrated that the expression of activated Ras induced an invasive phenotype in the rat, but not in the human fibroblasts. These studies provide evidence for the existence of human-specific mechanisms that resist Ras/MEK/ERK-mediated transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007212     DOI: 10.1038/sj.onc.1208724

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts.

Authors:  Kyoko Kakumoto; Ken Sasai; Taiko Sukezane; Chitose Oneyama; Satoshi Ishimaru; Kana Shibutani; Hiroto Mizushima; Eisuke Mekada; Hidesaburo Hanafusa; Tsuyoshi Akagi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-28       Impact factor: 11.205

2.  Regulation of chondrocyte differentiation by actin-severing protein adseverin.

Authors:  Dmitry Nurminsky; Cordula Magee; Lidia Faverman; Maria Nurminskaya
Journal:  Dev Biol       Date:  2006-10-06       Impact factor: 3.582

3.  O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies.

Authors:  Ken Sasai; Tsuyoshi Akagi; Eiko Aoyanagi; Kouichi Tabu; Sadao Kaneko; Shinya Tanaka
Journal:  Mol Cancer       Date:  2007-06-05       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.